CTOs on the Move


 
Someone to talk to
  • Number of Employees: 25-100
  • Annual Revenue: $10-50 Million
  • www.sibly.com
  • 2395, Broadway St
    Redwood City, CA USA 94063
  • Phone: 800.784.2433

Executives

Name Title Contact Details

Similar Companies

SNBL USA

SNBL USA is a part of the SNBL Group of companies and is a subsidiary of Shin Nippon Biomedical Laboratories (SNBL). As part of the SNBL Group, SNBL USA shares the corporate mission statement: We are committed to freeing patients from suffering by

Imperial Clinical Research Services

Imperial Clinical Research Services is a Grand Rapids, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Vita-Med Labs

Vita-Med Labs is a Mesa, AZ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

OneWorld

OneWorld provides quality affordable health care, and individuals are welcome with or without insurance, including Medicaid and Medicare. OneWorld operates 13 clinical locations in Omaha; including the clinics at the Historic Livestock Exchange Campus, OneWorld West, Northwest Omaha, Cass Family Medicine, OneWorld Bellevue, Crossroads to Health and Recovery at Community Alliance, two mobile dental clinics, four school-based health centers and the South Omaha Learning Community Centers. Established in 1970, OneWorld Community Health Centers, in partnership with the community, provides culturally respectful, quality health care with special attention to the underserved. OneWorld is a federally qualified health center (FQHC) and provides comprehensive primary health care, dental, mental health/ substance abuse services, and affordable medications.

Integrated Diagnostics

At Indi we believe that a systems-based approach is necessary to understand complex diseases and improve health. Our mission is to dramatically improve diagnosis and management of complex diseases by building advanced molecular diagnostics and creating new diagnostic technologies. We seek to understand the complex biological systems from which diseases arise so that we can determine which combinations of biomarkers have the greatest diagnostic power. Then we build assays capable of measuring hundreds of proteins at a time, for more precise detection and management of disease. Our end goal is to create large-scale systems medicine diagnostics that can gather a wealth of information – and then make sense of that information so that physicians can better diagnose disease.